Log In
person
Moderna Inc
MRNA
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Blockchain |
Blockchain-Enabled Supply Chain Management for Pharmaceutical Companies
These companies provide a broad range of services that are centered around supplier selection for pharmaceutical companies.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| mRNA Medicines |
Vaccines
These companies research, develop, and manufacture vaccines.
|
6.67B | 97.42% |
| mRNA Medicines |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0.18B | 2.58% |
| keyboard_arrow_down |
Blockchain
Blockchain-Enabled Supply Chain Management for Pharmaceutical Companies
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies provide a broad range of services that are centered around supplier selection for pharmaceutical companies.
|
||
| keyboard_arrow_down |
mRNA Medicines
Vaccines
|
6.67B | 97.42% |
| keyboard_arrow_right |
These companies research, develop, and manufacture vaccines.
|
||
| keyboard_arrow_down |
mRNA Medicines
Pre-Revenue Pharmaceuticals
|
0.18B | 2.58% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||